ヒトオルガノイド市場:提供形態、種類、培養方法、由来、疾患領域、用途、エンドユーザー別 ― 2031年までの世界市場予測Human Organoids Market by Offering, Type, Culture Type, Source, Disease Area, Application, End User - Global Forecast to 2031 世界のヒトオルガノイド市場は、2026年の0.29億米ドルから、2031年までに0.90億米ドルに達すると予測されており、年平均成長率(CAGR)は25.6%となる見込みです。 製薬企業や研究機関が、ヒト組織生物学の主要... もっと見る
英語原文をAIを使って翻訳しています。
サマリー世界のヒトオルガノイド市場は、2026年の0.29億米ドルから、2031年までに0.90億米ドルに達すると予測されており、年平均成長率(CAGR)は25.6%となる見込みです。 製薬企業や研究機関が、ヒト組織生物学の主要な特徴を再現するモデルを採用するにつれ、世界のヒトオルガノイド市場は予測期間中に拡大すると見込まれています。本調査では、医療および製薬用途向けの完成品オルガノイドモデル、モデル開発、ならびにオルガノイドを用いた試験サービスを対象としています。 別途販売される培地、試薬、消耗品、機器は対象外であり、化粧品、獣医、食品、農業、環境用途も対象外となる。FDAが2025年4月に発表したロードマップは、オルガノイドを用いた毒性試験を含む、検証済みの非動物試験法の評価を支持している。 疾患特異的なモデルやスケーラブルなスクリーニングへの需要は、サプライヤーにとってビジネスチャンスとなる。一方で、コスト、専門的なノウハウ、バッチ間のばらつき、組織の成熟度の不完全さなどが導入の障壁となり得るため、慎重な検証が必要となる。 すぐに使用でき、カスタマイズ可能なオルガノイドモデルは、ヒトに関連する研究システムへの活用を可能にします。 腸および大腸のオルガノイドモデルは、消化器系の研究やがん検診のニーズに応えるものです。 予測期間中、オルガノイド研究サービスはアジア太平洋地域においてビジネスチャンスを拡大している。 ヒトオルガノイドに関する調査の主な回答者カテゴリーは以下の通りです。 本調査の対象企業一覧 調査対象分野 本レポートを購入する主なメリット 本レポートでは、以下のポイントについて洞察を提供しています: 目次1 はじめに 39 2 概要 44 3 プレミアム・インサイト 51 4 市場の概要 55 5 業界の動向 62 6 技術の進歩、AIがもたらす影響、イノベーション、および将来の応用 80 7 規制環境と持続可能性への取り組み 88 8 顧客の動向と購買行動 95 9 ヒトオルガノイド市場:提供内容別 101 10 ヒトオルガノイドモデル市場(モデルタイプ別) 117 11 ヒトオルガノイドモデル市場:培養タイプ別 133 12 ヒトオルガノイドモデル市場(由来別) 143 13 疾患分野別ヒトオルガノイド市場 153 14 ヒトオルガノイド市場:用途別 170 15 ヒトオルガノイドモデル市場(エンドユーザー別) 186 16 ヒトオルガノイドサービス市場:エンドユーザー別 196 17 ヒトオルガノイド市場:地域別 206 18 競争環境 311 19 企業概要 329 20 研究方法論 382 21 付録 395 図表リストFIGURE 1 HUMAN ORGANOIDS MARKET SEGMENTATION 40.FIGURE 2 HUMAN ORGANOIDS MARKET: YEARS CONSIDERED 42. FIGURE 3 MARKET SCENARIO 44. FIGURE 4 GLOBAL HUMAN ORGANOID MODELS MARKET, 2023–2031 45. FIGURE 5 GLOBAL HUMAN ORGANOID SERVICES MARKET, 2023–2031 45. FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HUMAN ORGANOIDS MARKET, 2023–2026 46. FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF HUMAN ORGANOIDS MARKET 47. FIGURE 8 HIGH-GROWTH SEGMENTS IN HUMAN ORGANOIDS MARKET, 2026–2031 48. FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HUMAN ORGANOID MODELS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 49. FIGURE 10 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HUMAN ORGANOID SERVICES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 50. FIGURE 11 INCREASING ADOPTION OF HUMAN ORGANOID MODELS IN DRUG DISCOVERY TO PROPEL THE HUMAN ORGANOIDS MARKET 51. FIGURE 12 US AND SERVICES ACCOUNTED FOR LARGEST SHARE OF THE HUMAN ORGANOIDS MARKET IN NORTH AMERICA IN 2025 52. FIGURE 13 ASIA PACIFIC LIKELY TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 53. FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 54. FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 54. FIGURE 16 HUMAN ORGANOIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,. AND CHALLENGES 55. FIGURE 17 GLOBAL HUMAN ORGANOIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 62. FIGURE 18 GLOBAL HUMAN ORGANOID MODELS MARKET: VALUE CHAIN ANALYSIS 66. FIGURE 19 GLOBAL HUMAN ORGANOIDS SERVICES MARKET: VALUE CHAIN ANALYSIS 68. FIGURE 20 GLOBAL HUMAN ORGANOIDS MARKET: ECOSYSTEM ANALYSIS 70. FIGURE 21 HUMAN ORGANOIDS MARKET: TRENDS/DISRUPTIONS IMPACTING. CUSTOMER BUSINESS 74. FIGURE 22 TOP APPLICANTS & OWNERS (COMPANIES) FOR HUMAN ORGANOIDS PATENTS, 2015–DECEMBER 2025 83. FIGURE 23 IMPACT OF AI/GEN AI ON THE GLOBAL HUMAN ORGANOIDS MARKET 85. FIGURE 24 ILLUSTRATIVE STAKEHOLDER INFLUENCE, BY OFFERING 96. FIGURE 25 ILLUSTRATIVE BUYING PRIORITIES, BY END USER 97. FIGURE 26 NORTH AMERICA: HUMAN ORGANOIDS MARKET SNAPSHOT 208. FIGURE 27 ASIA PACIFIC: HUMAN ORGANOIDS MARKET SNAPSHOT 255. FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN HUMAN ORGANOIDS MARKET. (2023–2025) 313. FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HUMAN ORGANOIDS MARKET (2025) 314. FIGURE 30 HUMAN ORGANOIDS MARKET: COMPANY EVALUATION MATRIX. (KEY PLAYERS), 2025 316. FIGURE 31 HUMAN ORGANOIDS MARKET: COMPANY FOOTPRINT 317. FIGURE 32 HUMAN ORGANOIDS MARKET: COMPANY EVALUATION MATRIX. (STARTUPS/SMES), 2025 322. FIGURE 33 EV/EBITDA OF KEY VENDORS 325. FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 325. FIGURE 35 HUMAN ORGANOIDS MARKET: BRAND COMPARISON 326. FIGURE 36 MERCK: COMPANY SNAPSHOT 330. FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT 335. FIGURE 38 SAMSUNG BIOLOGICS: COMPANY SNAPSHOT 338. FIGURE 39 WUXI APPTEC: COMPANY SNAPSHOT 342. FIGURE 40 EVOTEC SE: COMPANY SNAPSHOT 346. FIGURE 41 ACROBIOSYSTEMS: COMPANY SNAPSHOT 351. FIGURE 42 ORGANOID SCIENCES, INC.: COMPANY SNAPSHOT 356. FIGURE 43 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 361. FIGURE 44 BRUKER CORPORATION: COMPANY SNAPSHOT 365. FIGURE 45 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT 368. FIGURE 46 PHARMARON: COMPANY SNAPSHOT 370. FIGURE 47 HUMAN ORGANOIDS MARKET: RESEARCH DESIGN METHODOLOGY 382. FIGURE 48 HUMAN OGRANOIDS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 384. FIGURE 49 GLOBAL HUMAN ORGANOIDS MARKET ESTIMATION, 2025 385. FIGURE 50 HUMAN ORGANOIDS MARKET: COMPANY REVENUE ANALYSIS. (BOTTOM-UP APPROACH) (2025) 386. FIGURE 51 HUMAN ORGANOIDS MARKET: INSIGHTS FROM PRIMARIES 387. FIGURE 52 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 388. FIGURE 53 HUMAN ORGANOIDS MARKET: CAGR PROJECTIONS 390. FIGURE 54 DATA TRIANGULATION METHODOLOGY 392. TABLE 1 HUMAN ORGANOIDS MARKET: INCLUSIONS & EXCLUSIONS 41. TABLE 2 HUMAN ORGANOIDS MARKET: IMPACT ANALYSIS 56. TABLE 3 GLOBAL HUMAN ORGANOIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 63. TABLE 4 GLOBAL HUMAN ORGANOIDS MARKET: KEY MODEL AND SERVICE PROVIDERS 70. TABLE 5 GLOBAL HUMAN ORGANOIDS MARKET: PRODUCTION SITES AND CAPABILITY DEVELOPMENTS 71. TABLE 6 AVERAGE SELLING PRICE OF HUMAN ORGANOIDS, BY PRODUCT/ SERVICE, 2025 72. TABLE 7 GLOBAL HUMAN ORGANOIDS MARKET: KEY CONFERENCES & EVENTS,. 2026–2027 73. TABLE 8 HUMAN ORGANOIDS MARKET: INDICATIVE LIST OF PATENTS, 2024–2025 84. TABLE 9 CASE STUDIES OF AI IMPLEMENTATION IN THE GLOBAL HUMAN ORGANOIDS MARKET 86. TABLE 10 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE GLOBAL HUMAN ORGANOIDS MARKET 87. TABLE 11 HUMAN ORGANOIDS REGULATORY GUIDANCE/FRAMEWORK, BY OFFERING 88. TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89. TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90. TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91. TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92. TABLE 16 ILLUSTRATIVE STAKEHOLDER INFLUENCE, BY MODEL TYPE (%) 96. TABLE 17 ILLUSTRATIVE BUYING CRITERIA, BY END USER 97. TABLE 18 HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 102. TABLE 19 HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION) 103. TABLE 20 HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 103. TABLE 21 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 103. TABLE 22 EUROPE: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 104. TABLE 23 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 104. TABLE 24 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 105. TABLE 25 READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 105. TABLE 26 NORTH AMERICA: READY-TO-USE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 106. TABLE 27 EUROPE: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 106. TABLE 28 ASIA PACIFIC: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 107. TABLE 29 LATIN AMERICA: READY-TO-USE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 107. TABLE 30 CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 108. TABLE 31 NORTH AMERICA: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 108. TABLE 32 EUROPE: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 108. TABLE 33 ASIA PACIFIC: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 109. TABLE 34 LATIN AMERICA: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 109. TABLE 35 HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 110. TABLE 36 HUMAN ORGANOID MODEL SERVICES MARKET, BY REGION,. 2023–2031 (USD MILLION) 110. TABLE 37 NORTH AMERICA: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110. TABLE 38 EUROPE: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 111. TABLE 39 ASIA PACIFIC: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 111. TABLE 40 LATIN AMERICA: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 112. TABLE 41 HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 112. TABLE 42 NORTH AMERICA: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113. TABLE 43 EUROPE: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 113. TABLE 44 ASIA PACIFIC: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 45 LATIN AMERICA: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 46 HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 115. TABLE 47 NORTH AMERICA: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115. TABLE 48 EUROPE: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 115. TABLE 49 ASIA PACIFIC: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 116. TABLE 50 LATIN AMERICA: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 116. TABLE 51 HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 118. TABLE 52 LIVER MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 119. TABLE 53 NORTH AMERICA: LIVER MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 119. TABLE 54 EUROPE: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 119. TABLE 55 ASIA PACIFIC: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 120. TABLE 56 LATIN AMERICA: LIVER MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 120. TABLE 57 INTESTINAL & COLORECTAL MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 121. TABLE 58 NORTH AMERICA: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 121. TABLE 59 EUROPE: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 121. TABLE 60 ASIA PACIFIC: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 122. TABLE 61 LATIN AMERICA: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 122. TABLE 62 KIDNEY MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 123. TABLE 63 NORTH AMERICA: KIDNEY MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 123. TABLE 64 EUROPE: KIDNEY MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 123. TABLE 65 ASIA PACIFIC: KIDNEY MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 124. TABLE 66 LATIN AMERICA: KIDNEY MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 124. TABLE 67 PANCREATIC MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 125. TABLE 68 NORTH AMERICA: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 125. TABLE 69 EUROPE: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 125. TABLE 70 ASIA PACIFIC: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 126. TABLE 71 LATIN AMERICA: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 126. TABLE 72 LUNG MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 127. TABLE 73 NORTH AMERICA: LUNG MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 127. TABLE 74 EUROPE: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 127. TABLE 75 ASIA PACIFIC: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 128. TABLE 76 LATIN AMERICA: LUNG MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 128. TABLE 77 HEART MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 129. TABLE 78 NORTH AMERICA: HEART MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 129. TABLE 79 EUROPE: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 129. TABLE 80 ASIA PACIFIC: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 130. TABLE 81 LATIN AMERICA: HEART MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 130. TABLE 82 OTHER HUMAN ORGANOID MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 131. TABLE 83 NORTH AMERICA: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 131. TABLE 84 EUROPE: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 131. TABLE 85 ASIA PACIFIC: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 132. TABLE 86 LATIN AMERICA: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 132. TABLE 87 HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE,. 2023–2031 (USD MILLION) 134. TABLE 88 HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE,. BY REGION, 2023–2031 (USD MILLION) 135. TABLE 89 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 90 EUROPE: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 91 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 136. TABLE 92 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 136. TABLE 93 HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY REGION, 2023–2031 (USD MILLION) 137. TABLE 94 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 95 EUROPE: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE,. BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 96 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 97 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 98 HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY REGION,. 2023–2031 (USD MILLION) 139. TABLE 99 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION,. BY COUNTRY, 2023–2031 (USD MILLION) 139. TABLE 100 EUROPE: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY COUNTRY, 2023–2031 (USD MILLION) 139. TABLE 101 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION,. BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 102 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION,. BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 103 HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY REGION, 2023–2031 (USD MILLION) 141. TABLE 104 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION) 141. TABLE 105 EUROPE: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES,. BY COUNTRY, 2023–2031 (USD MILLION) 141. TABLE 106 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION) 142. TABLE 107 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION) 142. TABLE 108 HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION) 144. TABLE 109 PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET,. BY REGION, 2023–2031 (USD MILLION) 145. TABLE 110 NORTH AMERICA: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145. TABLE 111 EUROPE: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145. TABLE 112 ASIA PACIFIC: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 113 LATIN AMERICA: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 114 ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 147. TABLE 115 NORTH AMERICA: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 147. TABLE 116 EUROPE: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 147. TABLE 117 ASIA PACIFIC: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 148. TABLE 118 LATIN AMERICA: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 148. TABLE 119 EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET,. BY REGION, 2023–2031 (USD MILLION) 149. TABLE 120 NORTH AMERICA: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 121 EUROPE: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 122 ASIA PACIFIC: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 123 LATIN AMERICA: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 124 OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY REGION,. 2023–2031 (USD MILLION) 151. TABLE 125 NORTH AMERICA: OTHER HUMAN ORGANOID MODEL SOURCES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 151. TABLE 126 EUROPE: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 151. TABLE 127 ASIA PACIFIC: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 128 LATIN AMERICA: OTHER HUMAN ORGANOID MODEL SOURCES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 129 HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION) 154. TABLE 130 INCIDENCE OF CANCER CASES WORLDWIDE, IN 2022 VS 2045, BY CANCER TYPE 155. TABLE 131 HUMAN ORGANOID MARKET FOR ONCOLOGY, BY REGION,. 2023–2031 (USD MILLION) 155. TABLE 132 NORTH AMERICA: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 155. TABLE 133 EUROPE: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY,. 2023–2031 (USD MILLION) 156. TABLE 134 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY,. 2023–2031 (USD MILLION) 156. TABLE 135 LATIN AMERICA: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 157. TABLE 136 HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY REGION, 2023–2031 (USD MILLION) 157. TABLE 137 NORTH AMERICA: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY,. 2023–2031 (USD MILLION) 158. TABLE 138 EUROPE: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION) 158. TABLE 139 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION) 159. TABLE 140 LATIN AMERICA: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY,. 2023–2031 (USD MILLION) 159. TABLE 141 HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2031 (USD MILLION) 160. TABLE 142 NORTH AMERICA: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 143 EUROPE: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 144 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 161. TABLE 145 LATIN AMERICA: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 161. TABLE 146 HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023–2031 (USD MILLION) 162. TABLE 147 NORTH AMERICA: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 162. TABLE 148 EUROPE: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 162. TABLE 149 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 150 LATIN AMERICA: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 151 HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY REGION,. 2023–2031 (USD MILLION) 164. TABLE 152 NORTH AMERICA: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 164. TABLE 153 EUROPE: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 164. TABLE 154 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 165. TABLE 155 LATIN AMERICA: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 165. TABLE 156 HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY REGION,. 2023–2031 (USD MILLION) 166. TABLE 157 NORTH AMERICA: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 158 EUROPE: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS,. BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 159 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS,. BY COUNTRY, 2023–2031 (USD MILLION) 167. TABLE 160 LATIN AMERICA: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS,. BY COUNTRY, 2023–2031 (USD MILLION) 167. TABLE 161 HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY REGION,. 2023–2031 (USD MILLION) 168. TABLE 162 NORTH AMERICA: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS,. BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 163 EUROPE: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 164 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS,. BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 165 LATIN AMERICA: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS,. BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 166 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 171. TABLE 167 HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY REGION, 2023–2031 (USD MILLION) 172. TABLE 168 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION) 172. TABLE 169 EUROPE: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING,. BY COUNTRY, 2023–2031 (USD MILLION) 172. TABLE 170 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 171 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 172 HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY REGION, 2023–2031 (USD MILLION) 174. TABLE 173 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION) 174. TABLE 174 EUROPE: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING,. BY COUNTRY, 2023–2031 (USD MILLION) 174. TABLE 175 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION) 175. TABLE 176 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION) 175. TABLE 177 HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY REGION,. 2023–2031 (USD MILLION) 176. TABLE 178 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DISEASE MODELING,. BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 179 EUROPE: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 180 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION) 177. TABLE 181 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DISEASE MODELING,. BY COUNTRY, 2023–2031 (USD MILLION) 177. TABLE 182 HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION,. 2023–2031 (USD MILLION) 178. TABLE 183 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 178. TABLE 184 EUROPE: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 178. TABLE 185 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 186 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 187 HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE, BY REGION,. 2023–2031 (USD MILLION) 180. TABLE 188 NORTH AMERICA: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 180. TABLE 189 EUROPE: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 180. TABLE 190 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 181. TABLE 191 LATIN AMERICA: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 181. TABLE 192 HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE, BY REGION,. 2023–2031 (USD MILLION) 182. TABLE 193 NORTH AMERICA: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 194 EUROPE: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 195 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 183. TABLE 196 LATIN AMERICA: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 183. TABLE 197 HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY REGION,. 2023–2031 (USD MILLION) 184. TABLE 198 NORTH AMERICA: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS,. BY COUNTRY, 2023–2031 (USD MILLION) 184. TABLE 199 EUROPE: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 184. TABLE 200 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS,. BY COUNTRY, 2023–2031 (USD MILLION) 185. TABLE 201 LATIN AMERICA: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS,. BY COUNTRY, 2023–2031 (USD MILLION) 185. TABLE 202 HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 187. TABLE 203 HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION) 188. TABLE 204 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 188. TABLE 205 EUROPE: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 188. TABLE 206 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 189. TABLE 207 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 189. TABLE 208 HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION) 190. TABLE 209 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 190. TABLE 210 EUROPE: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 190. TABLE 211 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 191. TABLE 212 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 191. TABLE 213 HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS, BY REGION,. 2023–2031 (USD MILLION) 192. TABLE 214 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 192. TABLE 215 EUROPE: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 192. TABLE 216 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 193. TABLE 217 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 193. TABLE 218 HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY REGION,. 2023–2031 (USD MILLION) 194. TABLE 219 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 194. TABLE 220 EUROPE: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 194. TABLE 221 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 195. TABLE 222 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 195. TABLE 223 HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION) 197. TABLE 224 HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION) 198. TABLE 225 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 198. TABLE 226 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 198. TABLE 227 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 199. TABLE 228 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 199. TABLE 229 HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION) 200. TABLE 230 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 200. TABLE 231 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 200. TABLE 232 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 201. TABLE 233 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 201. TABLE 234 HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS, BY REGION,. 2023–2031 (USD MILLION) 202. TABLE 235 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 202. TABLE 236 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 202. TABLE 237 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 203. TABLE 238 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 203. TABLE 239 HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION) 204. TABLE 240 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 204. TABLE 241 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 204. TABLE 242 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 205. TABLE 243 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 205. TABLE 244 HUMAN ORGANOIDS MARKET, BY REGION, 2023–2031 (USD MILLION) 207. TABLE 245 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 208. TABLE 246 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY OFFERING,. 2023–2031 (USD MILLION) 209. TABLE 247 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE,. 2023–2031 (USD MILLION) 209. TABLE 248 NORTH AMERICA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION) 209. TABLE 249 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 210. TABLE 250 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION) 210. TABLE 251 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE,. 2023–2031 (USD MILLION) 211. TABLE 252 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA,. 2023–2031 (USD MILLION) 211. TABLE 253 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION,. 2023–2031 (USD MILLION) 212. TABLE 254 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 212. TABLE 255 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET, BY END USER,. 2023–2031 (USD MILLION) 213. TABLE 256 US: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 213. TABLE 257 US: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION) 214. TABLE 258 US: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 214. TABLE 259 US: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 214. TABLE 260 US: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE,. 2023–2031 (USD MILLION) 215. TABLE 261 US: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE,. 2023–2031 (USD MILLION) 215. TABLE 262 US: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION) 216. TABLE 263 US: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 216. TABLE 264 US: HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 217. TABLE 265 US: HUMAN ORGANOID SERVICES MARKET, BY END USER,. 2023–2031 (USD MILLION) 217. TABLE 266 CANADA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 218. TABLE 267 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE,. 2023–2031 (USD MILLION) 218. TABLE 268 CANADA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 218. TABLE 269 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 219. TABLE 270 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE,. 2023–2031 (USD MILLION) 219. TABLE 271 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE,. 2023–2031 (USD MILLION) 220. TABLE 272 CANADA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA,. 2023–2031 (USD MILLION) 220. TABLE 273 CANADA: HUMAN ORGANOIDS MARKET, BY APPLICATION,. 2023–2031 (USD MILLION) 221. TABLE 274 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 221. TABLE 275 CANADA: HUMAN ORGANOID SERVICES MARKET, BY END USER,. 2023–2031 (USD MILLION) 222. TABLE 276 EUROPE: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 222. TABLE 277 EUROPE: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 223. TABLE 278 EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY TYPE,. 2023–2031 (USD MILLION) 223. TABLE 279 EUROPE: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 223.
SummaryThe global human organoids market is projected to reach USD 0.90 billion by 2031 from USD 0.29 billion in 2026, at a CAGR of 25.6%. The global human organoids market is expected to expand during the forecast period as pharmaceutical and research organizations adopt models that capture key features of human tissue biology. The study covers finished organoid models and model development and organoid-based testing services for medical and pharmaceutical applications. Separately sold media, reagents, consumables, and instruments are excluded, as are cosmetic, veterinary, food, agricultural, and environmental uses. The FDA’s April 2025 roadmap supports evaluating validated non-animal methods, including organoid toxicity testing. Demand for disease-specific models and scalable screening creates opportunities for suppliers. Costs, specialized expertise, batch variability, and incomplete tissue maturation can limit adoption and require careful validation. Ready-to-use and customizable organoid models support access to human-relevant research systems. Intestinal and colorectal organoid models address gastrointestinal research and oncology screening needs. Organoid research services are expanding opportunities in Asia Pacific during the forecast period. Primary research respondent categories for the human organoids study include: List of Companies Covered in the Study Research Coverage Key Benefits of Buying the Report The report provides insights into the following pointers: Table of Contents1 INTRODUCTION 39 2 EXECUTIVE SUMMARY 44 3 PREMIUM INSIGHTS 51 4 MARKET OVERVIEW 55 5 INDUSTRY TRENDS 62 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, INNOVATIONS, AND FUTURE APPLICATIONS 80 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 88 8 CUSTOMER LANDSCAPE & BUYING BEHAVIOR 95 9 HUMAN ORGANOIDS MARKET, BY OFFERING 101 10 HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE 117 11 HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE 133 12 HUMAN ORGANOIDS MODELS MARKET, BY SOURCE 143 13 HUMAN ORGANOIDS MARKET, BY DISEASE AREA 153 14 HUMAN ORGANOIDS MARKET, BY APPLICATION 170 15 HUMAN ORGANOID MODELS MARKET, BY END USER 186 16 HUMAN ORGANOID SERVICES MARKET, BY END USER 196 17 HUMAN ORGANOIDS MARKET, BY REGION 206 18 COMPETITIVE LANDSCAPE 311 19 COMPANY PROFILES 329 20 RESEARCH METHODOLOGY 382 21 APPENDIX 395 List of Tables/GraphsFIGURE 1 HUMAN ORGANOIDS MARKET SEGMENTATION 40.FIGURE 2 HUMAN ORGANOIDS MARKET: YEARS CONSIDERED 42. FIGURE 3 MARKET SCENARIO 44. FIGURE 4 GLOBAL HUMAN ORGANOID MODELS MARKET, 2023–2031 45. FIGURE 5 GLOBAL HUMAN ORGANOID SERVICES MARKET, 2023–2031 45. FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HUMAN ORGANOIDS MARKET, 2023–2026 46. FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF HUMAN ORGANOIDS MARKET 47. FIGURE 8 HIGH-GROWTH SEGMENTS IN HUMAN ORGANOIDS MARKET, 2026–2031 48. FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HUMAN ORGANOID MODELS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 49. FIGURE 10 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HUMAN ORGANOID SERVICES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 50. FIGURE 11 INCREASING ADOPTION OF HUMAN ORGANOID MODELS IN DRUG DISCOVERY TO PROPEL THE HUMAN ORGANOIDS MARKET 51. FIGURE 12 US AND SERVICES ACCOUNTED FOR LARGEST SHARE OF THE HUMAN ORGANOIDS MARKET IN NORTH AMERICA IN 2025 52. FIGURE 13 ASIA PACIFIC LIKELY TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 53. FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 54. FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 54. FIGURE 16 HUMAN ORGANOIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,. AND CHALLENGES 55. FIGURE 17 GLOBAL HUMAN ORGANOIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 62. FIGURE 18 GLOBAL HUMAN ORGANOID MODELS MARKET: VALUE CHAIN ANALYSIS 66. FIGURE 19 GLOBAL HUMAN ORGANOIDS SERVICES MARKET: VALUE CHAIN ANALYSIS 68. FIGURE 20 GLOBAL HUMAN ORGANOIDS MARKET: ECOSYSTEM ANALYSIS 70. FIGURE 21 HUMAN ORGANOIDS MARKET: TRENDS/DISRUPTIONS IMPACTING. CUSTOMER BUSINESS 74. FIGURE 22 TOP APPLICANTS & OWNERS (COMPANIES) FOR HUMAN ORGANOIDS PATENTS, 2015–DECEMBER 2025 83. FIGURE 23 IMPACT OF AI/GEN AI ON THE GLOBAL HUMAN ORGANOIDS MARKET 85. FIGURE 24 ILLUSTRATIVE STAKEHOLDER INFLUENCE, BY OFFERING 96. FIGURE 25 ILLUSTRATIVE BUYING PRIORITIES, BY END USER 97. FIGURE 26 NORTH AMERICA: HUMAN ORGANOIDS MARKET SNAPSHOT 208. FIGURE 27 ASIA PACIFIC: HUMAN ORGANOIDS MARKET SNAPSHOT 255. FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN HUMAN ORGANOIDS MARKET. (2023–2025) 313. FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HUMAN ORGANOIDS MARKET (2025) 314. FIGURE 30 HUMAN ORGANOIDS MARKET: COMPANY EVALUATION MATRIX. (KEY PLAYERS), 2025 316. FIGURE 31 HUMAN ORGANOIDS MARKET: COMPANY FOOTPRINT 317. FIGURE 32 HUMAN ORGANOIDS MARKET: COMPANY EVALUATION MATRIX. (STARTUPS/SMES), 2025 322. FIGURE 33 EV/EBITDA OF KEY VENDORS 325. FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 325. FIGURE 35 HUMAN ORGANOIDS MARKET: BRAND COMPARISON 326. FIGURE 36 MERCK: COMPANY SNAPSHOT 330. FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT 335. FIGURE 38 SAMSUNG BIOLOGICS: COMPANY SNAPSHOT 338. FIGURE 39 WUXI APPTEC: COMPANY SNAPSHOT 342. FIGURE 40 EVOTEC SE: COMPANY SNAPSHOT 346. FIGURE 41 ACROBIOSYSTEMS: COMPANY SNAPSHOT 351. FIGURE 42 ORGANOID SCIENCES, INC.: COMPANY SNAPSHOT 356. FIGURE 43 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 361. FIGURE 44 BRUKER CORPORATION: COMPANY SNAPSHOT 365. FIGURE 45 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT 368. FIGURE 46 PHARMARON: COMPANY SNAPSHOT 370. FIGURE 47 HUMAN ORGANOIDS MARKET: RESEARCH DESIGN METHODOLOGY 382. FIGURE 48 HUMAN OGRANOIDS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 384. FIGURE 49 GLOBAL HUMAN ORGANOIDS MARKET ESTIMATION, 2025 385. FIGURE 50 HUMAN ORGANOIDS MARKET: COMPANY REVENUE ANALYSIS. (BOTTOM-UP APPROACH) (2025) 386. FIGURE 51 HUMAN ORGANOIDS MARKET: INSIGHTS FROM PRIMARIES 387. FIGURE 52 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 388. FIGURE 53 HUMAN ORGANOIDS MARKET: CAGR PROJECTIONS 390. FIGURE 54 DATA TRIANGULATION METHODOLOGY 392. TABLE 1 HUMAN ORGANOIDS MARKET: INCLUSIONS & EXCLUSIONS 41. TABLE 2 HUMAN ORGANOIDS MARKET: IMPACT ANALYSIS 56. TABLE 3 GLOBAL HUMAN ORGANOIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 63. TABLE 4 GLOBAL HUMAN ORGANOIDS MARKET: KEY MODEL AND SERVICE PROVIDERS 70. TABLE 5 GLOBAL HUMAN ORGANOIDS MARKET: PRODUCTION SITES AND CAPABILITY DEVELOPMENTS 71. TABLE 6 AVERAGE SELLING PRICE OF HUMAN ORGANOIDS, BY PRODUCT/ SERVICE, 2025 72. TABLE 7 GLOBAL HUMAN ORGANOIDS MARKET: KEY CONFERENCES & EVENTS,. 2026–2027 73. TABLE 8 HUMAN ORGANOIDS MARKET: INDICATIVE LIST OF PATENTS, 2024–2025 84. TABLE 9 CASE STUDIES OF AI IMPLEMENTATION IN THE GLOBAL HUMAN ORGANOIDS MARKET 86. TABLE 10 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE GLOBAL HUMAN ORGANOIDS MARKET 87. TABLE 11 HUMAN ORGANOIDS REGULATORY GUIDANCE/FRAMEWORK, BY OFFERING 88. TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89. TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90. TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91. TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92. TABLE 16 ILLUSTRATIVE STAKEHOLDER INFLUENCE, BY MODEL TYPE (%) 96. TABLE 17 ILLUSTRATIVE BUYING CRITERIA, BY END USER 97. TABLE 18 HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 102. TABLE 19 HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION) 103. TABLE 20 HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 103. TABLE 21 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 103. TABLE 22 EUROPE: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 104. TABLE 23 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 104. TABLE 24 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 105. TABLE 25 READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 105. TABLE 26 NORTH AMERICA: READY-TO-USE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 106. TABLE 27 EUROPE: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 106. TABLE 28 ASIA PACIFIC: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 107. TABLE 29 LATIN AMERICA: READY-TO-USE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 107. TABLE 30 CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 108. TABLE 31 NORTH AMERICA: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 108. TABLE 32 EUROPE: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 108. TABLE 33 ASIA PACIFIC: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 109. TABLE 34 LATIN AMERICA: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 109. TABLE 35 HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 110. TABLE 36 HUMAN ORGANOID MODEL SERVICES MARKET, BY REGION,. 2023–2031 (USD MILLION) 110. TABLE 37 NORTH AMERICA: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 110. TABLE 38 EUROPE: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 111. TABLE 39 ASIA PACIFIC: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 111. TABLE 40 LATIN AMERICA: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 112. TABLE 41 HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 112. TABLE 42 NORTH AMERICA: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 113. TABLE 43 EUROPE: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 113. TABLE 44 ASIA PACIFIC: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 45 LATIN AMERICA: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 114. TABLE 46 HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION) 115. TABLE 47 NORTH AMERICA: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 115. TABLE 48 EUROPE: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 115. TABLE 49 ASIA PACIFIC: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 116. TABLE 50 LATIN AMERICA: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 116. TABLE 51 HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 118. TABLE 52 LIVER MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 119. TABLE 53 NORTH AMERICA: LIVER MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 119. TABLE 54 EUROPE: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 119. TABLE 55 ASIA PACIFIC: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 120. TABLE 56 LATIN AMERICA: LIVER MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 120. TABLE 57 INTESTINAL & COLORECTAL MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 121. TABLE 58 NORTH AMERICA: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 121. TABLE 59 EUROPE: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 121. TABLE 60 ASIA PACIFIC: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 122. TABLE 61 LATIN AMERICA: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 122. TABLE 62 KIDNEY MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 123. TABLE 63 NORTH AMERICA: KIDNEY MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 123. TABLE 64 EUROPE: KIDNEY MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 123. TABLE 65 ASIA PACIFIC: KIDNEY MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 124. TABLE 66 LATIN AMERICA: KIDNEY MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 124. TABLE 67 PANCREATIC MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 125. TABLE 68 NORTH AMERICA: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 125. TABLE 69 EUROPE: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 125. TABLE 70 ASIA PACIFIC: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 126. TABLE 71 LATIN AMERICA: PANCREATIC MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 126. TABLE 72 LUNG MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 127. TABLE 73 NORTH AMERICA: LUNG MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 127. TABLE 74 EUROPE: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 127. TABLE 75 ASIA PACIFIC: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 128. TABLE 76 LATIN AMERICA: LUNG MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 128. TABLE 77 HEART MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 129. TABLE 78 NORTH AMERICA: HEART MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 129. TABLE 79 EUROPE: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 129. TABLE 80 ASIA PACIFIC: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 130. TABLE 81 LATIN AMERICA: HEART MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 130. TABLE 82 OTHER HUMAN ORGANOID MODELS MARKET, BY REGION,. 2023–2031 (USD MILLION) 131. TABLE 83 NORTH AMERICA: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 131. TABLE 84 EUROPE: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 131. TABLE 85 ASIA PACIFIC: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 132. TABLE 86 LATIN AMERICA: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 132. TABLE 87 HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE,. 2023–2031 (USD MILLION) 134. TABLE 88 HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE,. BY REGION, 2023–2031 (USD MILLION) 135. TABLE 89 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 90 EUROPE: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 135. TABLE 91 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 136. TABLE 92 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION) 136. TABLE 93 HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY REGION, 2023–2031 (USD MILLION) 137. TABLE 94 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 95 EUROPE: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE,. BY COUNTRY, 2023–2031 (USD MILLION) 137. TABLE 96 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 97 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION) 138. TABLE 98 HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY REGION,. 2023–2031 (USD MILLION) 139. TABLE 99 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION,. BY COUNTRY, 2023–2031 (USD MILLION) 139. TABLE 100 EUROPE: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY COUNTRY, 2023–2031 (USD MILLION) 139. TABLE 101 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION,. BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 102 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION,. BY COUNTRY, 2023–2031 (USD MILLION) 140. TABLE 103 HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY REGION, 2023–2031 (USD MILLION) 141. TABLE 104 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION) 141. TABLE 105 EUROPE: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES,. BY COUNTRY, 2023–2031 (USD MILLION) 141. TABLE 106 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION) 142. TABLE 107 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION) 142. TABLE 108 HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION) 144. TABLE 109 PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET,. BY REGION, 2023–2031 (USD MILLION) 145. TABLE 110 NORTH AMERICA: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145. TABLE 111 EUROPE: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 145. TABLE 112 ASIA PACIFIC: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 113 LATIN AMERICA: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 146. TABLE 114 ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION) 147. TABLE 115 NORTH AMERICA: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 147. TABLE 116 EUROPE: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 147. TABLE 117 ASIA PACIFIC: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 148. TABLE 118 LATIN AMERICA: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 148. TABLE 119 EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET,. BY REGION, 2023–2031 (USD MILLION) 149. TABLE 120 NORTH AMERICA: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 121 EUROPE: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 149. TABLE 122 ASIA PACIFIC: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 123 LATIN AMERICA: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 150. TABLE 124 OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY REGION,. 2023–2031 (USD MILLION) 151. TABLE 125 NORTH AMERICA: OTHER HUMAN ORGANOID MODEL SOURCES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 151. TABLE 126 EUROPE: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 151. TABLE 127 ASIA PACIFIC: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 128 LATIN AMERICA: OTHER HUMAN ORGANOID MODEL SOURCES MARKET,. BY COUNTRY, 2023–2031 (USD MILLION) 152. TABLE 129 HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION) 154. TABLE 130 INCIDENCE OF CANCER CASES WORLDWIDE, IN 2022 VS 2045, BY CANCER TYPE 155. TABLE 131 HUMAN ORGANOID MARKET FOR ONCOLOGY, BY REGION,. 2023–2031 (USD MILLION) 155. TABLE 132 NORTH AMERICA: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 155. TABLE 133 EUROPE: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY,. 2023–2031 (USD MILLION) 156. TABLE 134 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY,. 2023–2031 (USD MILLION) 156. TABLE 135 LATIN AMERICA: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION) 157. TABLE 136 HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY REGION, 2023–2031 (USD MILLION) 157. TABLE 137 NORTH AMERICA: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY,. 2023–2031 (USD MILLION) 158. TABLE 138 EUROPE: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION) 158. TABLE 139 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION) 159. TABLE 140 LATIN AMERICA: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY,. 2023–2031 (USD MILLION) 159. TABLE 141 HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2031 (USD MILLION) 160. TABLE 142 NORTH AMERICA: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 143 EUROPE: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 160. TABLE 144 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 161. TABLE 145 LATIN AMERICA: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 161. TABLE 146 HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023–2031 (USD MILLION) 162. TABLE 147 NORTH AMERICA: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 162. TABLE 148 EUROPE: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 162. TABLE 149 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 150 LATIN AMERICA: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 163. TABLE 151 HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY REGION,. 2023–2031 (USD MILLION) 164. TABLE 152 NORTH AMERICA: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 164. TABLE 153 EUROPE: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION) 164. TABLE 154 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 165. TABLE 155 LATIN AMERICA: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES,. BY COUNTRY, 2023–2031 (USD MILLION) 165. TABLE 156 HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY REGION,. 2023–2031 (USD MILLION) 166. TABLE 157 NORTH AMERICA: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 158 EUROPE: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS,. BY COUNTRY, 2023–2031 (USD MILLION) 166. TABLE 159 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS,. BY COUNTRY, 2023–2031 (USD MILLION) 167. TABLE 160 LATIN AMERICA: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS,. BY COUNTRY, 2023–2031 (USD MILLION) 167. TABLE 161 HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY REGION,. 2023–2031 (USD MILLION) 168. TABLE 162 NORTH AMERICA: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS,. BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 163 EUROPE: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2023–2031 (USD MILLION) 168. TABLE 164 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS,. BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 165 LATIN AMERICA: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS,. BY COUNTRY, 2023–2031 (USD MILLION) 169. TABLE 166 HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 171. TABLE 167 HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY REGION, 2023–2031 (USD MILLION) 172. TABLE 168 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION) 172. TABLE 169 EUROPE: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING,. BY COUNTRY, 2023–2031 (USD MILLION) 172. TABLE 170 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 171 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION) 173. TABLE 172 HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY REGION, 2023–2031 (USD MILLION) 174. TABLE 173 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION) 174. TABLE 174 EUROPE: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING,. BY COUNTRY, 2023–2031 (USD MILLION) 174. TABLE 175 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION) 175. TABLE 176 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION) 175. TABLE 177 HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY REGION,. 2023–2031 (USD MILLION) 176. TABLE 178 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DISEASE MODELING,. BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 179 EUROPE: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION) 176. TABLE 180 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION) 177. TABLE 181 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DISEASE MODELING,. BY COUNTRY, 2023–2031 (USD MILLION) 177. TABLE 182 HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION,. 2023–2031 (USD MILLION) 178. TABLE 183 NORTH AMERICA: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 178. TABLE 184 EUROPE: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 178. TABLE 185 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 186 LATIN AMERICA: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY,. BY COUNTRY, 2023–2031 (USD MILLION) 179. TABLE 187 HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE, BY REGION,. 2023–2031 (USD MILLION) 180. TABLE 188 NORTH AMERICA: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 180. TABLE 189 EUROPE: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 180. TABLE 190 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 181. TABLE 191 LATIN AMERICA: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 181. TABLE 192 HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE, BY REGION,. 2023–2031 (USD MILLION) 182. TABLE 193 NORTH AMERICA: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 194 EUROPE: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 182. TABLE 195 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 183. TABLE 196 LATIN AMERICA: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE,. BY COUNTRY, 2023–2031 (USD MILLION) 183. TABLE 197 HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY REGION,. 2023–2031 (USD MILLION) 184. TABLE 198 NORTH AMERICA: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS,. BY COUNTRY, 2023–2031 (USD MILLION) 184. TABLE 199 EUROPE: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION) 184. TABLE 200 ASIA PACIFIC: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS,. BY COUNTRY, 2023–2031 (USD MILLION) 185. TABLE 201 LATIN AMERICA: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS,. BY COUNTRY, 2023–2031 (USD MILLION) 185. TABLE 202 HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 187. TABLE 203 HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION) 188. TABLE 204 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 188. TABLE 205 EUROPE: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 188. TABLE 206 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 189. TABLE 207 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 189. TABLE 208 HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION) 190. TABLE 209 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 190. TABLE 210 EUROPE: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 190. TABLE 211 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 191. TABLE 212 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 191. TABLE 213 HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS, BY REGION,. 2023–2031 (USD MILLION) 192. TABLE 214 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 192. TABLE 215 EUROPE: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 192. TABLE 216 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 193. TABLE 217 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 193. TABLE 218 HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY REGION,. 2023–2031 (USD MILLION) 194. TABLE 219 NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 194. TABLE 220 EUROPE: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 194. TABLE 221 ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 195. TABLE 222 LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 195. TABLE 223 HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION) 197. TABLE 224 HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION) 198. TABLE 225 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 198. TABLE 226 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 198. TABLE 227 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 199. TABLE 228 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION) 199. TABLE 229 HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION) 200. TABLE 230 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 200. TABLE 231 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 200. TABLE 232 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 201. TABLE 233 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION) 201. TABLE 234 HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS, BY REGION,. 2023–2031 (USD MILLION) 202. TABLE 235 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 202. TABLE 236 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 202. TABLE 237 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 203. TABLE 238 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS,. BY COUNTRY, 2023–2031 (USD MILLION) 203. TABLE 239 HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION) 204. TABLE 240 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 204. TABLE 241 EUROPE: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 204. TABLE 242 ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS,. BY COUNTRY, 2023–2031 (USD MILLION) 205. TABLE 243 LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION) 205. TABLE 244 HUMAN ORGANOIDS MARKET, BY REGION, 2023–2031 (USD MILLION) 207. TABLE 245 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY,. 2023–2031 (USD MILLION) 208. TABLE 246 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY OFFERING,. 2023–2031 (USD MILLION) 209. TABLE 247 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE,. 2023–2031 (USD MILLION) 209. TABLE 248 NORTH AMERICA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION) 209. TABLE 249 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 210. TABLE 250 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION) 210. TABLE 251 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE,. 2023–2031 (USD MILLION) 211. TABLE 252 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA,. 2023–2031 (USD MILLION) 211. TABLE 253 NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION,. 2023–2031 (USD MILLION) 212. TABLE 254 NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 212. TABLE 255 NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET, BY END USER,. 2023–2031 (USD MILLION) 213. TABLE 256 US: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 213. TABLE 257 US: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION) 214. TABLE 258 US: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 214. TABLE 259 US: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 214. TABLE 260 US: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE,. 2023–2031 (USD MILLION) 215. TABLE 261 US: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE,. 2023–2031 (USD MILLION) 215. TABLE 262 US: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION) 216. TABLE 263 US: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION) 216. TABLE 264 US: HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 217. TABLE 265 US: HUMAN ORGANOID SERVICES MARKET, BY END USER,. 2023–2031 (USD MILLION) 217. TABLE 266 CANADA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 218. TABLE 267 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE,. 2023–2031 (USD MILLION) 218. TABLE 268 CANADA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 218. TABLE 269 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE,. 2023–2031 (USD MILLION) 219. TABLE 270 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE,. 2023–2031 (USD MILLION) 219. TABLE 271 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE,. 2023–2031 (USD MILLION) 220. TABLE 272 CANADA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA,. 2023–2031 (USD MILLION) 220. TABLE 273 CANADA: HUMAN ORGANOIDS MARKET, BY APPLICATION,. 2023–2031 (USD MILLION) 221. TABLE 274 CANADA: HUMAN ORGANOIDS MODELS MARKET, BY END USER,. 2023–2031 (USD MILLION) 221. TABLE 275 CANADA: HUMAN ORGANOID SERVICES MARKET, BY END USER,. 2023–2031 (USD MILLION) 222. TABLE 276 EUROPE: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION) 222. TABLE 277 EUROPE: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION) 223. TABLE 278 EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY TYPE,. 2023–2031 (USD MILLION) 223. TABLE 279 EUROPE: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE,. 2023–2031 (USD MILLION) 223.
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
MarketsandMarkets社の Biotechnology分野 での最新刊レポート
本レポートと同じKEY WORD(source)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|